These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22024716)

  • 1. The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.
    Balu DT; Basu AC; Corradi JP; Cacace AM; Coyle JT
    Neurobiol Dis; 2012 Feb; 45(2):671-82. PubMed ID: 22024716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal D-serine regulates dendritic architecture in the somatosensory cortex.
    Balu DT; Coyle JT
    Neurosci Lett; 2012 May; 517(2):77-81. PubMed ID: 22521586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology.
    DeVito LM; Balu DT; Kanter BR; Lykken C; Basu AC; Coyle JT; Eichenbaum H
    Genes Brain Behav; 2011 Mar; 10(2):210-22. PubMed ID: 21029376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction.
    Jami SA; Cameron S; Wong JM; Daly ER; McAllister AK; Gray JA
    J Neurophysiol; 2021 Jul; 126(1):11-27. PubMed ID: 34038186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.
    Balu DT; Li Y; Puhl MD; Benneyworth MA; Basu AC; Takagi S; Bolshakov VY; Coyle JT
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):E2400-9. PubMed ID: 23729812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postsynaptic Serine Racemase Regulates NMDA Receptor Function.
    Wong JM; Folorunso OO; Barragan EV; Berciu C; Harvey TL; Coyle JT; Balu DT; Gray JA
    J Neurosci; 2020 Dec; 40(50):9564-9575. PubMed ID: 33158959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
    Takagi S; Balu DT; Coyle JT
    Schizophr Res; 2015 Mar; 162(1-3):216-21. PubMed ID: 25592804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of N-Methyl-d-Aspartate Receptor Coagonists Affects Cocaine-Induced Conditioned Place Preference and Locomotor Sensitization: Implications for Comorbid Schizophrenia and Substance Abuse.
    Puhl MD; Berg AR; Bechtholt AJ; Coyle JT
    J Pharmacol Exp Ther; 2015 Jun; 353(3):465-70. PubMed ID: 25788713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction.
    Balu DT; Coyle JT
    Neurochem Int; 2014 Sep; 75():76-8. PubMed ID: 24915645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.
    Pei JC; Hung WL; Lin BX; Shih MH; Lu LY; Luo DZ; Tai HC; Studer V; Min MY; Lai WS
    J Psychopharmacol; 2019 Oct; 33(10):1288-1302. PubMed ID: 31294644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.
    Jacobi AA; Halawani S; Lynch DR; Lin H
    Neurosci Lett; 2019 Jan; 692():107-114. PubMed ID: 30391323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers.
    Benneyworth MA; Roseman AS; Basu AC; Coyle JT
    Neurosci Lett; 2011 Jan; 488(3):267-71. PubMed ID: 21094213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forebrain expression of serine racemase during postnatal development.
    Folorunso OO; Harvey TL; Brown SE; Cruz C; Shahbo E; Ajjawi I; Balu DT
    Neurochem Int; 2021 May; 145():104990. PubMed ID: 33592203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered CREB Binding to Activity-Dependent Genes in Serine Racemase Deficient Mice, a Mouse Model of Schizophrenia.
    Balu DT; Coyle JT
    ACS Chem Neurosci; 2018 Sep; 9(9):2205-2209. PubMed ID: 29172439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal serine racemase regulates extracellular D-serine levels in the adult mouse hippocampus.
    Ishiwata S; Umino A; Balu DT; Coyle JT; Nishikawa T
    J Neural Transm (Vienna); 2015 Aug; 122(8):1099-103. PubMed ID: 25782690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons.
    Benneyworth MA; Li Y; Basu AC; Bolshakov VY; Coyle JT
    Cell Mol Neurobiol; 2012 May; 32(4):613-24. PubMed ID: 22362148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.
    Balu DT; Li Y; Takagi S; Presti KT; Ramikie TS; Rook JM; Jones CK; Lindsley CW; Conn PJ; Bolshakov VY; Coyle JT
    Neuropsychopharmacology; 2016 Jul; 41(8):2052-61. PubMed ID: 26741285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous co-agonists of the NMDA receptor modulate contextual fear in trace conditioning.
    Basu AC; Puhl MD; Coyle JT
    Neurobiol Learn Mem; 2016 Dec; 136():244-250. PubMed ID: 27633914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle.
    Neame S; Safory H; Radzishevsky I; Touitou A; Marchesani F; Marchetti M; Kellner S; Berlin S; Foltyn VN; Engelender S; Billard JM; Wolosker H
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20736-20742. PubMed ID: 31548413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse.
    Puhl MD; Desai RI; Takagi S; Presti KT; Doyle MR; Donahue RJ; Landino SM; Bergman J; Carlezon WA; Coyle JT
    Addict Biol; 2019 Jan; 24(1):40-50. PubMed ID: 29168271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.